TAIPEI (Reuters) – Thailand is prioritising AstraZeneca Plc COVID-19 vaccines produced in the country for itself due to the severity of the pandemic there, which has delayed deliveries to Taiwan, President Tsai Ing-wen said on Friday.
Taiwan is dealing with a spike in domestic infections and only 3% of its 23.5 million people have received at least one shot of a vaccination so far, with millions of doses on order that have yet to arrive.
“The problem is that the goods that were supposed to have arrived in June have not,” Tsai told a Taiwanese radio station.
Taiwan has ordered 10 million doses from AstraZeneca which is mainly producing the shots in Thailand, she said.
“Now Thailand’s epidemic situation is serious and they are giving priority for vaccines to be used in Thailand,” Tsai added.
Thailand has reported 189,828 infections, with over 80% of the new cases and fatalities coming since April.
AstraZeneca did not immediately respond to a request for comment.
Taiwan’s Health Minister Chen Shih-chung told lawmakers on Tuesday that orders from AstraZeneca would be delayed by a month due to production problems at the firm’s Thai plant.
Taiwan received 1.24 million AstraZeneca doses donated by Japan last week, and the United States has pledged 750,000 shots, but no details have been provided on that.
Tsai said the government had been having “emergency” talks with the United States and Japan to see what other vaccines they may be able to give.
(Reporting by Yimou Lee and Ben Blanchard; Editing by Lincoln Feast)
